• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐药结核病治疗中药物不良反应的研究。

Study of adverse drug reactions during the treatment of drug resistant tuberculosis.

机构信息

Department of Respiratory Medicine, Goa Medical College, Bambolim, Goa, 403202, India.

Department of Respiratory Medicine, Goa Medical College, Bambolim, Goa, 403202, India.

出版信息

Indian J Tuberc. 2024;71 Suppl 1:S136-S140. doi: 10.1016/j.ijtb.2024.03.002. Epub 2024 Mar 6.

DOI:10.1016/j.ijtb.2024.03.002
PMID:39067945
Abstract

BACKGROUND

Pharmacovigilance entails monitoring of patients for timely detection of ADR and reporting them so that more information about drug safety can be obtained. This may help in the future for dose modification or alteration of regimen. In NTEP, ADSm (Active Drug Safety monitoring) is part of pharmacovigilance. In this study we shall be studying ADRs to Anti TB drugs in DRTB.

METHODOLOGY

This study is observational, retrospective and record based, of patients admitted from 2021 to 2023 in the DOTS ward of Respiratory Medicine Department of a tertiary care hospital in Goa. Data such as age, sex, regimen, date of AKT initiation and adverse effects documented has been noted and compiled.

RESULTS

ADRs have been tabulated in the form of tables. Statistical analysis is done to find out the commonest ADR, time when they are likely to occur, which age and gender are most likely affected and if there are any other associated risk factors for ADRs.

CONCLUSION

This study will enable in future to better monitor patients with regard to particular adverse drug reaction, patient safety and if needed to alter the regimen as early as possible.

摘要

背景

药物警戒需要对患者进行监测,以便及时发现不良反应并报告,从而获得更多关于药物安全性的信息。这有助于在未来调整剂量或改变治疗方案。在国家结核病控制项目中,ADSm(主动药物安全监测)是药物警戒的一部分。在这项研究中,我们将研究耐多药结核病患者的抗结核药物不良反应。

方法

本研究是一项观察性、回顾性和基于记录的研究,对 2021 年至 2023 年期间在果阿一家三级护理医院呼吸内科 DOTS 病房住院的患者进行研究。记录并编制了年龄、性别、方案、AKT 起始日期和不良反应等数据。

结果

以表格形式列出了不良反应。进行了统计学分析,以找出最常见的不良反应、可能发生的时间、最容易受影响的年龄和性别,以及是否存在其他不良反应的相关风险因素。

结论

这项研究将有助于未来更好地监测特定药物不良反应、患者安全性的患者,并在需要时尽早改变治疗方案。

相似文献

1
Study of adverse drug reactions during the treatment of drug resistant tuberculosis.耐药结核病治疗中药物不良反应的研究。
Indian J Tuberc. 2024;71 Suppl 1:S136-S140. doi: 10.1016/j.ijtb.2024.03.002. Epub 2024 Mar 6.
2
Analysis of nationwide adverse event reports on Isoniazid and Rifampin in tuberculosis prevention and treatment in South Korea.韩国结核病预防和治疗中异烟肼与利福平的全国性不良事件报告分析
Sci Rep. 2025 Mar 3;15(1):7411. doi: 10.1038/s41598-025-91753-y.
3
Adverse drug reactions due to linezolid in the programmatic management of drug-resistant tuberculosis in India: A retrospective multicenter study.印度耐药结核病规划管理中利奈唑胺的药物不良反应:一项回顾性多中心研究。
Indian J Tuberc. 2024;71 Suppl 1:S101-S109. doi: 10.1016/j.ijtb.2023.04.006. Epub 2023 Apr 10.
4
Isoniazid mono-resistant tuberculosis: Time to take it seriously.异烟肼单耐药结核病:是时候认真对待了。
Indian J Tuberc. 2019 Apr;66(2):247-252. doi: 10.1016/j.ijtb.2019.04.001. Epub 2019 Apr 9.
5
High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.在印度西部,HIV 感染者中耐多药结核病的高发率。
BMC Infect Dis. 2019 May 8;19(1):391. doi: 10.1186/s12879-019-4042-z.
6
Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study protocol.结核病预防性治疗期间3个月异烟肼利福喷汀(3HP)相关药物不良反应(ADR)的临床预测因素(PAnDoRA - 3HP研究):一项观察性研究方案
BMJ Open. 2024 Dec 31;14(12):e088389. doi: 10.1136/bmjopen-2024-088389.
7
Evaluation of 3 Months of Once-Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection.评价利福喷丁和异烟肼治疗潜伏性结核病感染的 3 个月疗程。
Ann Pharmacother. 2020 May;54(5):457-463. doi: 10.1177/1060028019888855. Epub 2019 Nov 15.
8
'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.“在修订后的国家结核病控制规划下,我们是否漏报了药物不良反应?”——印度班加罗尔的一项混合方法研究。
Indian J Tuberc. 2020 Jan;67(1):20-28. doi: 10.1016/j.ijtb.2020.01.003. Epub 2020 Jan 15.
9
Adverse drug reactions in drug resistant pulmonary tuberculosis patients.耐药肺结核患者的药物不良反应。
Indian J Tuberc. 2024;71 Suppl 1:S25-S28. doi: 10.1016/j.ijtb.2023.06.001. Epub 2023 Jun 7.
10
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.耐药结核病治疗中不良反应监测:第一份全球报告。
Eur Respir J. 2019 Dec 19;54(6). doi: 10.1183/13993003.01522-2019. Print 2019 Dec.

引用本文的文献

1
..
IJID Reg. 2025 Mar 1;15:100615. doi: 10.1016/j.ijregi.2025.100615. eCollection 2025 Jun.
2
Editorial: The role of transcriptional regulation in mycobacterium physiology.社论:转录调控在分枝杆菌生理学中的作用
Front Cell Infect Microbiol. 2024 Sep 2;14:1483263. doi: 10.3389/fcimb.2024.1483263. eCollection 2024.